Csl Ltd (CMXHF)

CSL Ltd is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. The Company produces life-saving and life-enhancing medicines that enable people around the world to live a normal healthy life. It is a specialty biopharmaceutical company that researches, develops, manufactures and markets biotherapies to treat and prevent serious and rare medical conditions. The Company's areas of expertise are Plasma Products: Human plasma is used to produce a wide range of life-saving medicines. The key businesses involved with plasma products include: CSL Behring and CSL Behring (Australia). Vaccines & Pharmaceuticals: manufactures and provides influenza vaccine. The Company's segments are CSL Behring: manufactures, markets and develops plasma therapies (plasma products and recombination's); biosCSL: manufactures and distributes non-plasma biotherapeutic products and CSL Intellectual Property: revenue & associated expenses from the licensing if Intellectual Property generated by the group to unrelated third parties and Research & Development expenses. The Company operates in four geographical areas, namely Australia, USA, Switzerland and Germany.